期刊文献+

脐带间充质干细胞向成骨细胞分化的潜能 被引量:2

Potential of human umbilical cord mesenchymal stem cells differentiating into osteoblasts
下载PDF
导出
摘要 背景:人脐带间充质干细胞含量丰富,较为原始,分化能力强,免疫原性低,是细胞治疗的理想靶细胞。目的:体外分离培养脐带间充质干细胞并将其定向诱导为成骨细胞。方法:无菌条件下培养脐带间充质干细胞,分为诱导组和对照组,诱导组用成骨诱导液处理、对照组为干细胞培养液处理。倒置光显微镜观察细胞形态,MTT法测细胞增殖,荧光双染法检测细胞活力,流式细胞仪检测细胞周期与细胞表面标记。诱导后:检测碱性磷酸酶,Von Kossa染色分析钙盐沉积,RT-PCR检测骨桥蛋白基因、碱性磷酸酶、骨唾液蛋白mRNA的表达。结果与结论:传代细胞形态稳定、活力好,高标达CD44。诱导后vonKossa染色表现为阳性。碱性磷酸酶活性诱导组比对照组高(P<0.05),不同时间点比较21d最高(P<0.05)。RT-PCR显示:诱导组21,28d碱性磷酸酶mRNA表达均较与对照组增强(P<0.05)。诱导组有骨唾液蛋白和骨桥蛋白基因mRNA表达。提示,人脐带间充质干细胞能够定向分化为成骨细胞。 BACKGROUND:Human umbilical cord mesenchymal stem cells(UCMSCs) were rich and more primordial,had strong differentiation ability and low immunogenicity,suitable for transplanting to different individuals.Therefore,UCMSCs were an ideal target cells for cell therapy.OBJECTIVE:To study the isolation and culture of UCMSCs and to explore the potential of osteogenesis differentiation in vitro.METHODS:UCMSCs were sterilely isolated and cultured.The third passage of cells were divided into induction group and control group.The induction group was treated with ossify induction medium,and control group was treated with stem cell culture medium.The cell morphology was observed under an inverted light microscope.Cell proliferation was determined by MTT assay.The cell viability was detected by double immunofluorescent staining.Cell cycle and cell surface marker were determined using flow cytometry.Following induction,alkaline phosphatase(ALP) activity was measured utilizing microplate reader.Calcium deposition was analyzed using Von Kossa staining.mRNA expression of osteopontin(OPN),ALP and bone sialoprotein(BSP) was measured by reverse transplantation-polymerase chain reaction(RT-PCR).RESULTS AND CONCLUSION:The passage cells were steady in the cell shapes,with good viability,and highly expressed CD44.Following induction,the cells were positive in von Kossa staining.ALP activity was higher in induction group compared with control group(P 0.05).The ALP activity was greatest on day 21(P 0.05).RT-PCR indicated that ALP mRNA expression was higher in induction group compared with control group(P 0.05).The BSP and OPN genes were expressed in induction group,which suggested that human UCMSCs can differentiate into osteoblasts.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第40期7439-7442,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 武警部队科研项目(WY200806) 课题名称:FAK介导信号通路与人脐血间充质干细胞成骨化作用~~
  • 相关文献

参考文献6

二级参考文献57

  • 1鞠秀丽,黄志伟,时庆,侯怀水,段春红.体外扩增脐血间充质干细胞的生物学特性和诱导分化能力的研究[J].中华儿科杂志,2005,43(7):499-502. 被引量:17
  • 2Miao Z, Jin J, Chen L,et al. Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells. Cell Biol Int. 2006;30(9):681-687.
  • 3Kern S, Eichler H, Kluter H. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Braz J Med Biol Res. 2003; 36(9): 1179-1183.
  • 4Covas DT, Siufi JL, Silva AR.Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res. 2003;36(9):1179- 1183.
  • 5Hui JH, Li L, Teo YH. Comparative study of the ability of mesenchymal stem cells derived from bone marrow, periosteum, and adipose tissue in treatment of partial growth arrest in rabbit. Tissue Eng. 2005;11(5-6):904-912.
  • 6Romanov YA, Svintsitskaya VA ,Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells. 2003; 21(1):105-110.
  • 7Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25(6): 1384-1392.
  • 8Klyushnenkova E, Mosca JD, Zernetkina V.T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci. 2005;12(1):47-57.
  • 9Cho PS, MessinaDJ, Hirsh EL.Immunogenicity of Umbilical cord tissue derived cells. Blood.2008; 111(1 ):430-438.
  • 10Wang L, Lu XF, Lu YR, et al. Immunogenicity and immune modulation of osteogenic differentiated mesenchymal stem cells from Banna minipig inbred line. Transplant Proc. 2006;38(7): 2267-2269.

共引文献193

同被引文献40

  • 1史德海,蔡道章,周长忍,李立华,曾春,李晓峰.壳聚糖与型胶原复合制作组织工程软骨支架及其性能研究[J].中国修复重建外科杂志,2005,19(4):278-282. 被引量:29
  • 2Song K,Rao N,Chen M,et al. construction of adeno-as- sociated virus system for human bone morphogenetic pro- tein 7 gene [J]. Journal of Huazhong University of Sci- ence and Technology (Medlcal Sciences), 2008,28 ( 1 ) : 17-21.
  • 3Klokkevold PR,Vandemark L,Kenney EB,et al. Osteogenesisenhanced by chitosan (poly-N-acetyglucosamlno- glycan), in itro [J]. J Periodontol, 1996,67 ( 11 ) : 1170 - 1175.
  • 4Manjubala I, Scheler S, Bossert J,et al. Mineralisation of chitosan scaffolds with nano-apatite formation by double diffusion technique [ J ]. Acta Biomaterialia, 2006,2 ( 1 ) : 75-84.
  • 5Younger EM, Chapman MW. Morbidity at bone graft donor sites[J]. J Orthop Trauma, 1959,3(3) : 192-195.
  • 6Kizuki T,Ohgaki M,Ichinose S,et al. Specific response of osteoblast-like cells on hydroxypatite layer containing serum protein [J]. J Mater Sci Mater Meal,2006,17 (9): 859-867.
  • 7Chesnutt BM,Yuan Y,Buddington K,et al. Composite chitosan/nano-hydroxyapatite scaffolds induce osteocal- cin production by osteoblasts in vitro and support bone formation in vivo [J]. Tissue Eng Part A,2009,15(9): 2571-2579.
  • 8Wang X,Wenk E,Zhang X,et al. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteo- chondral tissue engineering [J]. J Control Release,2009, 134(2) :81-90.
  • 9Hodgkinson T,Yuan XF,Bayat A. Adult stem cells in tis- sue engineering [J]. Expert Rev Med Devices,2009,6 (6) :621-640.
  • 10Cordonnier T, Layrolle P, Gaillard J, et al. 3D environment on human mesenchymal stem cells differentiation for bone tissue engineering [J]. J Mater Sci Mater Med,2010,21 (3) :981-987.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部